RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
79 hedge funds and large institutions have $412M invested in Repros Therapeutics Inc. in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 26 closing their positions.
Holders
79
Holders Change
-13
Holders Change %
-14.13%
% of All Funds
2.29%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
13
Increased
31
Reduced
24
Closed
26
Calls
$17.7M
Puts
$11.8M
Net Calls
+$5.86M
Net Calls Change
-$18M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$18.4M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$30.9M |
| 3 |
PHS
3
PFM Health Sciences
San Francisco,
California
|
$28.2M |
| 4 |
PC
4
PointState Capital
New York
|
$4.94M |
| 5 |
5
Jennison Associates
New York
|
$27.4M |
